Ehrfeld Mikrotechnik ist ein führender Anbieter von Spitzenprodukten in der Mikroreaktionstechnik. Das Unternehmen gilt als renommierte Adresse rund um das Thema Flow Chemistry.
For CDMOs, the adoption of flow chemistry can provide a competitive advantage by improving efficiency, safety and quality, while reducing costs and development times.
Given the challenges the pharmaceutical industry is facing – secure material supply, reduce operation cost and increase flexibility, enhance sustainability and safety, innovate and reduce time-to-market – the sector is poised for a breakthrough of flow chemistry.
At an online roundtable event hosted by CHEManager, a group of industry experts discussed the reasons why microreaction technology (MRT) has not achieved the status for instance in fine chemicals and active ingredients production that one might expect as well as various business and production aspects of the technology.
After an initial euphoria, the use of microreaction technology stagnated, but it is now on the way to establishing itself in production. A world-scale system is currently being set up in China that uses the Miprowa technology from Ehrfeld Mikrotechnik.
